Search results for: Gene therapies
Filter search results
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…discounting to gene therapies could delay or prevent patients from accessing potentially transformative therapies. The discounting challenge is not unique to gene therapies. Other health technologies like cell therapies, vaccines,…
Exploring the Financial Sustainability of Gene Therapies
5 January 2021
…marketing approval and the size of the eligible patient populations will influence the total spend on gene therapies. As different gene therapies generate different kinds of value for the health…
New evaluation model finds widespread adoption of cell and gene therapies may unlock billions for the UK economy
20 October 2025
…of healthcare innovations, such as cell and gene therapies. It evaluates the economic gains that the large-scale adoption of advanced therapies could provide for individuals, the NHS, and the wider…
Challenges and Solutions for Budget Impact Analysis of Gene Therapies
10 March 2025
…therapies. When these models are likely to be employed, they should be factored into BIAs to inform decision making, commercial negotiations, and implementation. Share this: Download publication Gene therapies represent…
Are Recommendations for HTA of Gene Therapies Being Achieved?
11 September 2023
…demonstrating significant potential for improvement in the HTA of gene therapies. Share this: Download publication Several challenges are preventing timely access to gene therapies. Based on a review of the…
ISPOR Issue Panel Roundup: Are Our HTA Methods Fit for Purpose for Gene Therapies?
6 June 2022
…gene therapies have the potential to transform lives and provide further benefits for society and the health system. The development of these therapies presents a new combination of challenges and…
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…and discussed actionable recommendations resulting from an expert roundtable. The report identified four broad categories of challenges faced by gene therapies undergoing health technology assessment (HTA): initial assessment of clinical…
Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?
1 June 2022
…known monogenic (single gene) cause. In contrast to traditional small molecule medicines, gene therapies have the potential to correct underlying genetic defects, offering the potential for transformational health gains rather…
The value of cell and gene therapies to the UK economy
20 October 2025
…Report, The value of cell and gene therapies to the UK economy, was commissioned and funded by the Cell and Gene Therapy Catapult, with support from Innovate UK. Download infographic…